Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3929studies shown
Showing 3,326-3,350 of 3,929
CompletedNCT02047968

Wake and Light Therapy to In-patients With Major Depression: Efficacy, Predictors and Patient Experiences

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

DepressionOtherFrom 18 Years to 65 Years
Countries
Denmark
Sponsor
University of Aarhus
Condition
Depression
CompletedNCT02494050

Telemedicine for Women With Anhedonia in Bipolar and Unipolar Disorder

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

BipolarityOtherFrom 21 Years to 65 Years
Countries
United States
Sponsor
Northwestern University
Condition
Bipolarity
CompletedNCT00274677

Depression And Bipolarity

This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
GlaxoSmithKline
Condition
Bipolarity
CompletedNCT00531518

Early Detection and Intervention for the Prevention of Psychosis

This study exists to explore whether psychoeducation, a guided learning and support program, could improve care and understanding. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
MaineHealth
Condition
Schizophrenia
CompletedNCT00490542

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

This study exists to explore whether the medication Ziprasidone could improve care and understanding. Researchers are trying to understand whether the medication Ziprasidone can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Tufts Medical Center
Condition
Depression
CompletedNCT01828931

Lifestyle Intervention for Diabetes and Weight Management in Psychosis

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
WithdrawnNCT00447096

rTMS for Treatment of Depressed Phase of Bipolarity type II

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity
CompletedNCT01833897

NMDA Antagonists in Depression in bipolarity

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity
CompletedNCT01305408

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Brazil, Bulgaria, Croatia, Finland, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Ukraine, United States
Sponsor
Cephalon
Condition
Bipolarity
TerminatedNCT01467700

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolarity I

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 75 Years
Countries
Argentina, Chile, Colombia, Mexico, United States
Sponsor
Takeda
Condition
Depression
CompletedNCT00578383

Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Depression
CompletedNCT02423824

Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 45 Years
Countries
Canada
Sponsor
University Health Network, Toronto
Condition
Depression
CompletedNCT01072929

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Cephalon
Condition
Bipolarity
CompletedNCT01072630

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, Canada, France, Poland, South Africa, Spain, Ukraine, United States
Sponsor
Cephalon
Condition
Bipolarity
CompletedNCT01256177

Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Depression in bipolarity

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
AstraZeneca
Condition
Bipolarity
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
SuspendedNCT01557192

Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

DepressionOtherFrom 21 Years to 55 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Depression
CompletedNCT01409096

Study Using Pregnenolone to Treat Depression in bipolarity

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity
CompletedNCT01259427

Reducing Internalized Stigma in People With Serious Mental Illness

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
CompletedNCT01042496

Depression in bipolarity Before and After Lamotrigine Treatment

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
CompletedNCT01597141

Psychosis: Early Detection, Intervention and Prevention

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 35 Years
Countries
United States
Sponsor
MaineHealth
Condition
Schizophrenia
CompletedNCT02675712

Effect of African Drumming in Mood Disorders

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

DepressionOtherOver 18 Years
Countries
Global
Sponsor
University of Stellenbosch
Condition
Depression
CompletedNCT01487668

Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders

This study exists to explore whether symptom tracking and monitoring could improve care and understanding. Researchers are trying to understand whether symptom tracking and monitoring can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 99 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia